| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |